Asensi M., Medina I., Ortega A., Carretero J., Bano M.C., Obrador E., Estrela J.M. (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33:387-98 PubMed (15736313)

Plasma analysed without enzymatic deconjugation

Plasma Concentration (µmol/L)
Number Dose Multiple Dose Duration Time (minutes) Polyphenol Source
Name as described in publication
0 2.5 5 10 30 60
1 20 mg/kg bw Single Dose 0 1.1 0.7 0.3 0.07 0.03
trans-resveratrol
2 20 mg/kg bw Single Dose 0 0.7 1.2 0.4 0.1 0.07
trans-resveratrol
3 20 mg/kg bw Single Dose 0 2.6 1.7 0.2 0.04 0.02
trans-resveratrol
L)&chxp=1,50|3,50&chd=t:0.0,2.5,5.0,10.0,30.0,60.0|0.0,1.1,0.7,0.3,0.07,0.03|0.0,2.5,5.0,10.0,30.0,60.0|0.0,0.7,1.2,0.4,0.1,0.07|0.0,2.5,5.0,10.0,30.0,60.0|0.0,2.6,1.7,0.2,0.04,0